Respirology

AO-001: The effect of spectral leakage on the forced oscillation technique
AO-002: Acute altitude exposure in patients with treated versus untreated severe obstructive sleep apnoea
AO-003: Heterogeneous bronchoconstriction measured by ventilation single photon emission computed tomography/computed tomography (VSPECT/CT) is reduced after treatment in asthma
AO-004: Correction of Measured PaO₂ in Shunt Calculations
AO-005: Firefighting self-contained breathing apparatus is not an independent risk factor for airway hyperresponsiveness
AO-006: Proximal & Peripheral Airway Response to Direct & Indirect Bronchial Provocation in Untreated Asthma
AO-007: Asthma control questionnaire score in patients referred to a pulmonary function laboratory with airway hyperresponsiveness to mannitol
AO-008: Identifying contraindications for respiratory function testing – A need for greater medical officer education?
AO-009: Home spirometry in children with cystic fibrosis: A pilot study
AO-010: Increasing measurement number reduces within-session FOT variability but may be impractical in asthma and COPD
AO-011: Poor lung function tracks from childhood to young adulthood, and is associated with respiratory symptoms and asthma in 22 year old participants of the Western Australian Pregnancy (Raine study) Cohort
AO-012: Supported learning after a spirometry course improves Spirometry Certification pass rates
AO-013: Tracheal gas conditions during nasal oxygen supplementation: Heated-humidified high-flow nasal oxygen versus low-flow nasal oxygen
AO-014: Reversibility of airflow limitation. Audit of assessment and interpretation in TSANZ accredited lung function laboratories.

AP-001: Better predicted values for maximal inspiratory (MIPs) and expiratory (MEPs) respiratory muscle pressures are needed
AP-002: Changes in peripheral airway function at 12 months post allogeneic haematopoietic stem cell transplantation (allo-HSCT)
AP-003: Does maximal forced expiratory and maximal inspiratory manoeuvres of Spirometry have a significant impact on Forced Oscillation Technique (FOT)?
AP-004: Effect on the clinical interpretation of spirometry in elderly patients by replacement of NHANES III with GLI 2012 reference equations
AP-005: Guideline based use of spirometry in the diagnosis and management of hospital in-patients with Chronic Obstructive Pulmonary Disease in 2015
AP-006: Lower limit of normal range for obstruction. Audit of TSANZ accredited lung function laboratories
AP-007: Nasal nitric oxide concentrations vary over time in patients with Primary Ciliary Dyskinesia (PCD)
AP-009: Resting lung function may predict the response to altitude simulation in motor neuron disease
AP-010: Single-breath DLCO Measurement Variability in Traditional versus Real-time Diffusion
AP-011: Use of Salbutamol confounds results from single breath DLCO technique in some gas analysers.
AP-012: Wait time following a single breath diffusing capacity test has an impact on carboxyhaemoglobin levels
AP-013: Quality improvements in external proficiency testing for total haemoglobin

TSANZ Respiratory Nurses SIG Symposium
TO-001: Development of a Breathlessness Clinic for Patients with Chronic Obstructive Pulmonary Disease (COPD)
TO-002: Nurse Led Obstructive Sleep Apnea (OSA) Assessments: Impact of a change to referral criteria
TO-003: Presentation re development of newly established Integrated Respiratory Nursing Service in Canterbury
Nominated for review by Respiratory Nurses SIG
TO-004: Transforming respiratory care in Hawke's Bay (NZ): Engaging patients as informed partners in their own health care
TO-005: Nurses Confidence and Competence in Providing Inhaled Medication Education to Patients
TO-006: Respiratory nurses' knowledge and practice behaviours in copd-related advance care planning: Preliminary findings from a crosssectional survey study
TO-007: Improving patient flow and reducing bed block during Influenza season in a tertiary hospital
Asthma and Allergy 1
TO-008: Asthma control, airway inflammation and gut microbiome are improved by soluble fibre supplementation
TO-009: New measures of adherence to inhaled therapy in patients with asthma
TO-010: “I'm a person with asthma…not the asthma first.”: Personal experiences of severe asthma: A review
TO-011: Medication adherence in a difficult asthma population
TO-012: Improving asthma emergency department discharge processes
TO-013: Azithromycin reduces exacerbations in adults with persistent symptomatic eosinophilic asthma
Evidence-Based Medicine and Practice
TO-015: Pulmonary Rehabilitation Guidelines for Australia and New Zealand
TO-016: Understanding barriers and facilitators to Pulmonary Rehabilitation referral, uptake and participation using the Theoretical Domains Framework: A systematic review
TO-017: Antibiotics for persistent cough or wheeze following acute bronchiolitis in children (Review)
Lung Cancer
TO-018: TLG increases the specificity of PET-CT analysis of the mediastinum in NSCLC
TO-019: Preoperative exercise training for patients with non-small cell lung cancer: a Cochrane systematic review.
TO-020: Is it lung cancer?: Evaluating the performance of a “lung lesion for investigation” service at a new secondary hospital
TO-021: PLEURX Catheter Drainage Systems are a safe, effective and economical strategy for the management of malignant pleural effusion and ascites. A single Center Experience.
TO-022: A new lung cancer pathway in Auckland region reduces time to diagnosis and treatment
TO-023: MDT v non-MDT care in lung cancer: does co-morbidity status have an impact?
OLIV 1
TO-024: A Sit-to-Stand Test is useful to assess exercise oxygenation in patients with Interstitial Lung Disease
TO-025: Vascular remodelling is reversed following BMPR2-expressing endothelial progenitor cell therapy in a MCT-induced PAH rat model
TO-026: Reduced GCR, HDAC2 and Hsp90 in pro-inflammatory lymphocytes in the small airways during BOS
TO-027: Matrix metalloproteinase-7 (MMP7) may be a biomarker of early chronic lung rejection
TO-028: Dead space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension
TO-029: Oxygen attenuates oxidative stress in ILD patients with nocturnal and exercise-induced hypoxaemia
Primary Care
TO-030: High rates of respiratory symptoms and airways disease in mental health inpatients in a tertiary centre
TO-031: A qualitative study using innovative technology via a smartphone application to provide demonstrative inhaler technique education for asthma patients
TO-032: The debilitating burdens of living with severe asthma
TO-033: Quitting experiences and smoking cessation preferences of smokers in Australian general practices
TO-034: Diagnosis of COPD in Australian general practices: experience from the RADICALS trial
TO-035: Feasibility of a peer-led asthma and smoking prevention program (ASPP) in Australian schools with high Indigenous youth
TO-036: Response of airway epithelial cells to rhinovirus in an allergic cytokine environment
TO-037: Sex dependent effects on airway responsiveness of maternal hypoxia-induced intrauterine growth restricted juvenile mice
TO-038: Determinants of rhinovirus and nucleic acid induced cytokine production in a large cohort
TO-039: Measuring bronchial hyperresponsiveness using a more sophisticated biostatistical method: the linear mixed effects model
TO-040: Mechanical forces attenuate anti-viral immunity in primary human airway epithelial cells from asthmatic donors
TO-041: Potential protective role of microRNA-22 against airway remodelling
Cell Biology/Immunology 1
TO-042: Acute inhibition of NOTCH signalling ablates MUC5AC production in human airway epithelial cells from Asthmatic, Non-Asthmatic and COPD donors.
TO-043: Cigarette smoke-induced inflammation in macrophages is initiated by NLRP3/AIM2 inflammasomes: involvement of the sphingosine-1-phosphate (S1P) signalling
TO-044: Evaluating anti-CD20 therapy for STAT3-mediated lung fibrosis
TO-045: Interaction of dietary fatty acids with obesity-induced cytokines in primary pulmonary fibroblasts
TO-046: Novel role of inflammasomes in the molecular pathogenesis of emphysema
TO-047: Steroid resistant CD8+CD28^nullNKT-like pro-inflammatory cytotoxic cells in COPD
Chronic Obstructive Pulmonary Disease 3
TO-048: Effect of tiotropium and olodaterol, alone and with exercise training, on exercise endurance in COPD
TO-049: Responsiveness of two-minute walk distance after pulmonary rehabilitation in chronic obstructive pulmonary disease
No additional benefit for 6MWT or HADs in combining cognitive behavioural therapy and pulmonary rehabilitation
TO-051: Enhancement of training response following pulmonary rehabilitation with downhill walking: a randomised controlled trial.
TO-052: The effect on HRQoL of ongoing feedback during a maintenance walking program : An RCT
TO-053: Participants who do not achieve the MID in the 6MWT may still have a training-response
Paediatric
TO-054: Patients with X-linked retinitis pigmentosa have altered airway cilial function and structure
TO-055: Detection and definition of abnormal paediatric breath sounds using digital stethoscopes compared to standard auscultation
TO-056: The effect of particle size delivered by pressurized meter dose inhalers (pMDIs) in asthmatic adolescents
TO-057: Effects of in utero smoke exposure on lung function from infancy to adulthood and the contribution of Glutathione S-transferase polymorphisms
TO-058: Spectrum of Lung Damage in Primary Ciliary Dyskinesia as seen on Computed Tomography
TO-059: The ventilatory response to hypoxia remains blunted in preterm infants with bronchopulmonary dysplasia
TSANZ Ann Woolcock Young Investigator Awards
TO-060: PRAGMA-CF: a quantitative measure of structural lung disease in young children with cystic fibrosis.
TO-061: Identification of a plasma microRNA profile in pulmonary tuberculosis patients that is modulated by anti-microbial therapy
TO-062: Zinc dyshomeostasis and autophagy as critical determinants for airway epithelial dysfunction in COPD
TO-063: Identifying a novel therapeutic strategy for asthma: targeting airway epithelial cell restitution
TO-064: Persistent IL-33 in a preclinical chronic asthma model underpins rhinovirus-induced exacerbation by dampening antiviral immunity
TO-065: Self-perceived burden as a barrier to communication at the end of life in COPD
Asthma and Allergy 3
TO-066: Asthma and physical activity in childhood: Are they longitudinally related?
TO-067: Blood eosinophils and serum IgE predict response to omalizumab in patients with severe allergic asthma: INNOVATE trial post-hoc analysis
TO-068: Increased expression of IL-27 in neutrophilic asthma
TO-069: Risk factors for vocal cord dysfunction in a difficult asthma population
TO-070: Asthma gene signatures expression in bronchial biopsy
TO-071: Macrophages regulate the development of RSV induced asthma exacerbations
Cystic Fibrosis
TO-072: Investigating the non-ion channel effects of CFTR modulators on innate immune viral responses
TO-073: Molecular and proteomic approach to investigate abnormal iron homeostasis in the cystic fibrosis airway
TO-074: Structural determinants of long term functional outcomes in children with cystic fibrosis
TO-075: Face masks and cough etiquette reduce cough generated bioaerosols containing pseudomonas aeruginosa in patients with cystic fibrosis
TO-076: Differences in the lower airway microbiota of infants with and without cystic fibrosis
TO-077: The relationship between exercise capacity and hospitalisation in adult cystic fibrosis
Occupational & Environmental Lung Disease / Population Health 1
TO-078: Occupational lung diseases remain underreported and undercompensated in Australia
TO-079: Lifetime occupational exposures in a population-based sample of older Australian adults.
TO-080: Dust exposure impacts non-typeable Haemophilus influenzae infection of human airway epithelial cells
TO-081: Self-reported geogenic dust exposure is associated with increased severity of infectious diseases in Aboriginal children
TO-082: Resurgence of Coal Worker's Pneumoconiosis in QLD: Preliminary results from a Clinical, Occupational and Radiological Review
TO-083: Effect of in utero exposure to ceiling particles on post-natal lung function
Respiratory Infectious Diseases 1
TO-084: The Australasian Bronchiectasis Registry – early steps in mapping the impact of bronchiectasis in Australia and New Zealand
TO-085: The role of Bronchoalveolar lavage (BAL) in the diagnosis of opportunistic infection in immunocompromised haematology patients
TO-086: Community acquired respiratory virus detection: Comparing the diagnostic laboratory with the research laboratory
TO-087: Pleural procalcitonin is not useful in differentiating parapneumonic from other effusions
TO-088: Impact of a single educational intervention on antibiotic prescribing in pneumonia and COPD is not sustained beyond 6 months
TO-089: Elevated neutrophil–lymphocyte count ratio is associated with increased adverse outcome in influenza
Asthma and Allergy 4
TO-090: Saturated fatty acids, but not n-6 polyunsaturated fatty acids or carbohydrates, increase airway inflammation in non-obese asthmatics
TO-091: High fat diet-induced obesity promotes steroid-resistant asthma through an NLRP3 inflammasome-dependent mechanism
TO-092: Impaired induction of Slc26a4 promotes respiratory acidosis and severe, steroid-insensitive asthma
TO-093: Limited exacerbation of asthma symptoms by electronic-cigarette aerosol exposure in a mouse model of asthma
TO-094: Multidimensional assessment and targeted therapy of severe persistent asthma: A randomised controlled trial
TO-095: Physical inactivity and sedentary time in severe asthma
Cell Biology/Immunology 2
TO-096: Lung fibroblasts of IPF patients display senescence-like features in vitro
TO-097: Non-antibiotic macrolides restore airway macrophage phagocytic function with potential anti-inflammatory effects in chronic lung diseases
TO-098: Antenatal Vitamin C administration in sheep is protective against fetal hypoxemia-induced oxidative stress and airway remodelling in early adulthood
TO-099: Role of increased iron levels in the pathogenesis of lung disease
TO-100: Dysregulated STAT3 signaling induces and reinforces fibroblast senescence in lung fibroblasts of IPF patients
TO-101: Fiublin-1c plays critical roles in lung remodelling in idiopathic pulmonary fibrosis
Chronic Obstructive Pulmonary Disease 2
TO-102: Home-based rehabilitation for COPD using minimal resources: an economic evaluation
TO-103: Electrocardiograms and chest radiographs in patients with abnormal cardiac biomarkers during exacerbations of COPD
TO-104: MicroRNA-21 drives experimental chronic obstructive pulmonary disease through a SATB1/S100A9/NF-κB axis
TO-105: Relationship between TLCO, Emphysema Index, FEV1 and Pulmonary Artery Distensibility - a sub-analysis of the 4C cohort
TO-106: The prevalence of reduced transfer factor for carbon monoxide (TLCO) in smokers with normal spirometry
TO-107: Self-management interventions including COPD exacerbation action plans improve hospitalisation rate and health-related quality of life – a Cochrane review
Interventional Pulmonary / Bronchology 1
TO-108: EBUS TBNA pre-surgical staging highlights the importance of confirming cytological negativity in cases of technically N3 NSCLC on PET
TO-109: A novel management of distal active haemoptysis by an intrabronchial valve and TISSEEL
TO-110: Endobronchial valve insertion outcomes for emphysema: a retrospective analysis in a local public health network.
TO-111: EBUS TBNA sampling of regional lymph nodes as a substitute for biopsy for concomitant pulmonary nodules; strong supportive evidence of primary lung cancer from EBUS TBNA sample immunohistochemistry and PET
TO-112: Texture analysis using unconstrained regions of interests from radial EBUS images can help predict malignant aetiology
TO-113: Pre operative EBUS TBNA pre-surgical staging highlights the importance of confirming cytological negativity in cases of technically n3 disease on pet scans
OLIV 2
TO-114: Predicting life expectancy for pirfenidone and best supportive care in IPF (Encore)
TO-115: Long-term treatment with nintedanib in patients with idiopathic pulmonary fibrosis: an update from INPULSIS®-ON
TO-116: Twenty-four week decline in FVC predicts mortality at week 52 in the INPULSIS ® trials
TO-117: Biomarkers can predict disease progression in Idiopathic Pulmonary Fibrosis: Analysis from the Australian IPF Registry.
TO-118: Effect of continued pirfenidone treatment following ≥15% decline in 6MWD in IPF patients-pooled analysis (encore)
TO-119: Annual rate of FVC decline in patients with IPF treated with pirfenidone: pooled analysis (encore)
Physiology and Sleep 1
TO-120: Determining regional (over)distension in the mechanically ventilated lung in vivo using a laboratory X-ray source
TO-121: The effect of high-dose, high fine-particle fraction combination therapy on ventilation heterogeneity in uncontrolled asthma
TO-122: Heterogeneous bronchoconstriction in asthma on ventilation single photon emission computed tomography/computed tomography(VSPECT/CT) decreases after treatment
TO-123: Evidence of persistent hyperventilation following high altitude exposure
TO-124: Proximal & Peripheral Airway Response to Direct & Indirect Bronchial Provocation in Untreated Asthma
Chronic Obstructive Pulmonary Disease 3
TO-125: Complex medication regimens in chronic obstructive pulmonary disease (COPD) are associated with disease severity and comorbidities
TO-126: Long-term efficacy of A₁-PI therapy in RAPID and RAPID extension trials
TO-127: Omalizumab treatment response in a severe allergic asthma population with overlapping COPD
TO-128: Indacaterol/glycopyrronium (IND/GLY) reduces the risk of exacerbations versus salmeterol/fluticasone (SFC) in moderate-to-very severe COPD patients irrespective of prior ICS/LABA/LAMA therapy: the FLAME study
TO-129: Bronchodilator therapy and exercise added to self-management behaviour-modification: Effects on physical activity in COPD
TO-130: Effect of indacaterol/glycopyrronium (IND/GLY) vs salmeterol/fluticasone (SFC) on moderate or severe COPD exacerbations and lung function based on baseline blood eosinophil counts: Results from the FLAME study
Interventional Pulmonary / Bronchology 2
TO-131: Changes in lung function and forced oscillatory technique (FOT) parameters following bronchial thermoplasty (BT) in patients with refractory asthma
TO-132: 5 year single centre experience of airway stenting
TO-133: Identifying risk factors that predict poor tolerance in pneumothoraces following transthoracic needle biopsy (TTNB) of lung lesions.
TO-134: Safety and diagnostic yield of transbronchial lung cryobiopsy for diagnosis of interstitial lung disease
TO-135: Benefit of standard transbronchial biopsies after endobronchial ultrasound guided biopsies for peripheral lung lesions
TO-136: Reducing hospitalisation and procedures in malignant pleural effusion - results of the AMPLE randomised trial
Physiology and Sleep 2
TO-137: The impact of mechanical ventilation on regional gene expression
TO-138: Diurnal variability of lung function and its association with sleep among patients with COPD
1 Oostveen E et al, Respiratory impedance in healthy subjects: baseline values and bronchodilator response. ERJ. 2013 Dec;42(6):1513–23
TO-139: Lung ultrasound surface wave elastography – preliminary measurements in patients with interstitial lung diseases
TO-140: The ventilatory control contribution to obstructive sleep apnoea in Caucasian and Chinese patients.
TO-141: Quality of life and symptoms are related to forced oscillation mechanics during home-monitoring in COPD
TO-142: Randomised controlled trial of polysomnography titration of nocturnal non-invasive ventilation
Respiratory Infectious Diseases 2
TO-143: Ten year retrospective clinical audit of tuberculosis in far North Queensland
TO-144: Audit of tuberculosis screening for health care workers in the Hunter New England Health Service
TO-145: Transplanting the human respiratory virome
TO-146: Paediatric tuberculosis in Timor-Leste: opportunities for improving recognition, diagnosis and prevention
TO-147: Airway epithelial innate immune responses to coronaviruses
TO-148: Influenza and bacterial co-infections: the Gold Coast Hospital and Health Service (GCHHS) experience
Chronic Obstructive Pulmonary Disease 4
TO-149: Increased proportion of slow decliners in patients with alpha-1 protease inhibitor (A₁-PI) deficiency following treatment with A₁-PI
TO-150: Lysosomal-associated membrane protein 1 (LAMP-1) is upregulated in small airway epithelium of smokers and COPD: potential role in autophagy
TO-151: Evaluating blood eosinophils and exacerbation history to predict inhaled corticosteroids response in COPD
TO-152: Reduced pulmonary artery distensibility on dynamic CT correlates with increased emphysema and impaired right ventricular function
TO-153: Antimicrobial prescription in patients dying from chronic obstructive pulmonary disease
TO-154: Accuracy of transcutaneous carbon dioxide measurement for change over time
Late Breaking Abstracts
TOL-001: Lung function trajectories over the life span, their associated childhood factors and consequences: a population based longitudinal cohort
TOL-002: A fast track clinic improves diagnosis and treatment times for those investigated for lung cancer in rural New Zealand
TOL-003: DiffQuik stained cytology smears provide improved malignant cell DNA yields from lymph nodes at endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA)
TOL-004: Asthma control during pregnancy, 17q21 variants and childhood-onset asthma

Asthma and Allergy 1
TP-001: Assessing the asthma training and resource needs of urban and rural school nurses
TP-002: Are you on the team? The role of key players in allergic rhinitis management from the perspective of the patient
TP-003: Incorrect Inhaler Technique Impairs Quality Of Life Among Asthma Patients
TP-004: Body mass index and adipose tissue within the airway wall
TP-005: Flow cytometry-based profiling of immune cells in asthmatic sputum
TP-006: Airway and lung structure in adul"t rats previously subject to hypoxia-induced intrauterine growth restriction
TP-007: Maternal e-cigarette vaping enhances development of allergic asthma in the offspring
TP-008: Efficacy of tiotropium in patients aged 6–17 years with severe symptomatic asthma
TP-009: Once-daily tiotropium Respimat® add-on therapy improves PEF in participants aged 6–17 years with symptomatic asthma
TP-010: Safety of tiotropium Respimat® add-on therapy in patients aged 6–17 years with symptomatic asthma
TP-011: An analysis of the effect of azithromycin in persistent asthma, based on pre-specified asthma phenotypes
TP-012: Supporting the needs of parents as they transfer asthma medication management autonomy to their children: A parent's perspective
TP-013: Allergic rhinitis is suboptimally managed in the community
TPL-001: The association of long-term traffic-related air pollution exposure with asthma and poor lung function in middle age
Asthma and Allergy 2
TP-014: The impact of exhaled nitric oxide measurements in the outpatient clinic
TP-015: “I can't breathe, but it's no big deal”. Why do some patients feel that allergic rhinitis is trivial?
TP-016: Functional respiratory imaging demonstrates heterogeneous alterations in airway mechanics and airflow during bronchoconstriction
TP-017: Atopy in people aged 40 and over: Relation to airflow limitation
TP-018: Evaluation of spirometry use and implementation of asthma action plans in acute adult asthma
TP-019: Case report: Case of Erythema Multiforme after Pirfenidone treatment
TP-020: Review of asthma in pregnancy guidelines
TP-021: Usefulness of FeNO in outpatient setting
TP-022: Suitability of Australian electronic medical records to guide the design of the NOVELTY study
TP-023: Assessing the usability of a youth-centered asthma management and medication tracking mobile app
TP-024: Periostin in asthmatic and non-asthmatic adults of Chinese descent
TP-025: Development and usability testing of a tailored goal-setting self-management app for young people with asthma
TP-026: Participants perspectives of a telephone counseling patient support pilot for people with poorly controlled asthma
TP-027: Patient's nasal symptom management within a community pharmacy setting
TPL-002: Thunderstorm Asthma – revealing a hidden at-risk population
TPL-003: Thunderstorm Asthma: Patient outcomes and clinical review
TPL-004: Persistence of symptoms, prevalence of asthma diagnosis, asthma control, preventer use and asthma action plan implementation in those presenting with thunderstorm asthma
TPL-005: Prior history of asthma, undiagnosed asthma and prevalence of rhinitis and its severity in those presenting with thunderstorm asthma
TPL-006: Characteristics of hospital inpatients presenting with thunderstorm asthma
Cell Biology/Immunology
TP-029: Novel SETD7 splice variant affects cell response to bacteria
TP-030: A case of dasatinib-associated chylothorax in a patient with chronic myeloid leukaemia
TP-031: Effect of in utero exposure to ceiling particles on the early post-natal immune cell populations
TP-032: Primary airway epithelial cell responses to bacteriophage preparations to treat infection in cystic fibrosis
TP-033: Increased presence of hyper-segmented airway neutrophils in asthma and bronchiectasis patients
TP-034: Infliximab for treatment refractory sarcoidosis, a case report and review of literature
TP-035: Biomass smoke exposure enhances Rhinovirus-induced inflammation
TP-036: Innate T lymphocytes during pulmonary exacerbations of cystic fibrosis (CF), non-CF bronchiectasis (NCFB), COPD and asthma
TP-037: Effects of N-acetylcysteine intervention in vitro on primary human bronchial epithelial cells exposed to diesel emissions
TP-039: E-cigarettes cause increased cell death, apoptosis and altered cytokine profile of human bronchial epithelial cells
TP-040: Investigation of the CD1b lipid antigen presentation pathway in pulmonary COPD
TP-041: Innate immune macrophage response to NTHi and azithromycin in COPD
TP-042: The impact of iron oxide and silica on inflammatory responses in BEAS-2B Cells
TPL-007: Changes in lipid metabolism in mucopolysaccharidosis (MPS) IIIA mouse lung tissue and pulmonary surfactant
TPL-008: Th22 cells form a distinct Th lineage from Th17 cells in vitro with unique transcriptional properties and Tbet-dependent Th1 plasticity during influenza infection in vivo
Chronic Obstructive Pulmonary Disease 1
TP-043: Correlation between change in lung density and lung function parameters in treated alpha-1 protease inhibitor (A₁-PI) deficiency
TP-044: Decreased degranulating cells and mast cell population in the small airway wall of mild-moderate COPD is indicative of dysfunctional immunity
TP-045: Telemedicine to deliver personalised health care in chronic obstructive pulmonary disease may reduce hospital admissions
TP-046: Should I choose salbutamol or ipratropium in patients with wheeze and breathlessness?
TP-047: Treatment burden in chronic obstructive pulmonary disease
TP-048: Audit of lung function testing practices in Australian and New Zealand TSANZ accredited laboratories
TP-049: Relationship between self-reported exercise adherence and objective measures of physical activity during home-based pulmonary rehabilitation in people with COPD
TP-050: Efficacy of indacaterol/glycopyrronium (IND/GLY) versus salmeterol/fluticasone (SFC) on exacerbations and health status in GOLD Group D COPD patients: the FLAME study
TP-051: Acute effect of cigarette-smoke exposure on soleus muscle fiber type distribution and morphology in rats
TP-052: Exacerbation management and weight loss: health goals during home-based pulmonary rehabilitation
Chronic Obstructive Pulmonary Disease 2
TP-053: Choosing a faster walking speed for the endurance shuttle walk test may reduce the ceiling effect for this test in people with chronic obstructive pulmonary disease
TP-054: Snapshot of Asthma and COPD: Patient flow, adherence to guidelines, and implications of accurate documentation
TP-055: The volume fraction of collagen-IV is increased within the airway smooth muscle layer in COPD
TP-056: Proton pump inhibitor use in patients with chronic obstructive pulmonary disease: An opportunity to deprescribe?
TP-057: Acute Oxygen Prescription – Are we doing it right? An audit on compliance with oxygen prescription in Chronic Obstructive Pulmonary Disease (COPD) patients admitted to Wollongong hospital
TP-058: Patient education interventions provided by physiotherapists to patients with chronic obstructive pulmonary disease: The result of a scoping review
TP-059: An exploration of pain experiences and their meaning in people with chronic obstructive pulmonary disease
TP-060: Effects of listening to music during a constant endurance exercise test in people with COPD
TP-061: The story of your life and lung health: Pilot study of a life history approach
TP-062: Feasibility, acceptability and safety of downhill walking during pulmonary rehabilitation for patients with COPD: results from a randomised controlled trial
TP-063: Indacaterol/glycopyrronium (IND/GLY) reduces exacerbation and improves lung function versus salmeterol/fluticasone (SFC) in patients with and without prior ICS use: the FLAME study
TP-064: Profile of bacterial and viral pathogens in patients presenting to hospital with an acute exacerbation of COPD
TP-065: Improving inpatient management of COPD exacerbations using a COPD Pathway
TP-066: Guideline based use of spirometry in the diagnosis and management of hospital in-patients with Chronic Obstructive Pulmonary Disease in 2015
TPL-009: Feasibility of Community pharmacists screening for COPD
TPL-010: The interaction between air pollution and smoking in chronic obstructive pulmonary disease (COPD)
Chronic Obstructive Pulmonary Disease 3
TP-067: Role of RAGE and TLR4 in the regulation of intrapulmonary airway contraction following short-term cigarette smoke exposure in mice
TP-068: Inflammatory cytokine environment of COPD alters the airway epithelial responses to viral and bacterial stimuli
TP-069: M1 and M2 macrophage populations in the airways of smokers and COPD patients: insights from both airway tissue and lumen
TP-070: Effects of COPD guideline training on physicians’ awareness, knowledge and readiness to implement guidelines: a cluster randomized controlled trial
TP-071: Measurement of FEV₁ and arterial blood gases (ABGs) in patients admitted with an acute exacerbation of COPD to two Central Coast Local Health District (CCLHD) hospitals: level of compliance with COPD-X guidelines
TP-072: Characteristics of people with chronic obstructive pulmonary disease who respond to ground-based walking training
TP-073: Understanding M?ori preferences for healthcare services
TP-074: Postural abnormalities in people with chronic obstructive pulmonary disease (COPD)
TP-075: Discrepancies in perspectives of people with COPD and experts in COPD or public health management, concerning factors to improve physical activity, sedentary behaviour and sleep
TP-076: The pulmonary rehabilitation adapted index of self-efficacy (PRAISE) predicts improvements in physical activity following pulmonary rehabilitation in people with chronic obstructive pulmonary disease (COPD)
TP-077: Rates of vaccination in COPD patients requiring hospital admission
TP-078: A survey of air travel history in patients with chronic respiratory disease
TP-079: General Practitioners’ beliefs and experiences when caring for patients with severe Chronic Obstructive Pulmonary Disease and refractory breathlessness
TP-080: Hand held fans for breathlessness relief in COPD: physical properties and patient perceptions
TP-081: Improving access to rehabilitation: a chronic disease rehabilitation redesign project
Cystic Fibrosis
TP-082: The lung clearance index is elevated in children with cystic fibrosis admitted for pulmonary exacerbations
TP-083: Developing high efficiency gene transfer techniques using human air liquid interface cultures
TP-084: Early Cystic Fibrosis: Two trials are adequate to assess lung clearance index and clinical markers
TP-085: Bone Health in Tasmanian Adults with Cystic Fibrosis: an Audit
TP-086: Elevated IL-1α in paediatric CF airways is associated with neutrophilia, inflammation and structural lung changes
TP-087: Audit of prescribing, monitoring and dosage of Tobramycin within a metropolitan Cystic Fibrosis unit
TP-088: Extent of structural abnormalities is associated with occurrence of adverse respiratory events in young children with cystic fibrosis
TPL-011: Inflammatory markers can predict pulmonary exacerbations of cystic fibrosis
TPL-012: Hyperglycaemia on Continuous Glucose Monitoring in young children with Cystic Fibrosis
Interventional Pulmonary / Bronchology
TP-089: Fatal bleeding following intrapleural fibrinolysis
TP-090: GOLD COAST UNIVERSITY HOSPITAL (GCUH) TUNNELLED PLEURAL CATHETER AUDIT
TP-091: Evaluation of cryobiopsy during pleuroscopic procedures
TP-093: Pleural drains: how safe is our practice? An audit of pleural drain insertions at an Australian regional hospital
TP-094: Physician performed chest ultrasound: progress and future directions
TP-095: To evaluate the efficacy of the 19 G endobronchial ultrasound transbronchial aspiration needle in diagnosing mediastinal lesions
TP-096: Does listening to music reduce patient anxiety level during pleural procedures?
TP-097: Wheeziness after bronchial thermoplasty
TP-098: Case report: Effect of diaphragmatic hernia repair on pulmonary function
TP-099: An unusual case of endotracheal lipoma
TP-100: A clinical audit of pleural procedures performed at a new general secondary hospital
TP-101: Bronchial thermoplasty response in asthma is influenced by number of radiofrequency activations
TP-102: Transbronchial lung cryobiopsy - a new paradigm for limited post-mortem assessment
OLIV
TP-103: The electronic nose as a diagnostic tool in sarcoidosis
TP-104: Lung transplant survival in Tasmania: 1990–2016
TP-105: Autoantibodies associated with connective tissue disease are frequently demonstrated in interstitial lung disease
TP-106: Culture of PAH peripheral blood derived endothelial progenitor Cells allows isolation of exosomes and analysis of their surface markers
TP-107: Comprehensive pulmonary rehabilitation for interstitial lung disease: a consensus approach to identify core educational topics
TP-109: Patient reported outcome measures in idiopathic pulmonary Fibrosis: Analysis from the Australian IPF registry
TP-110: Physicians’ perspectives on the use of domiciliary oxygen therapy in interstitial lung disease
TP-111: Portable Oxygen Concentrator vs Oxygen Cylinder during Walking in ILD: A Randomised Crossover Trial
TP-112: Comparison of intrapulmonary artery and airway reactivity in precision cut lung slices from a rat model of pulmonary arterial hypertension
TP-113: Characterising vascular changes in a mouse model of bronchopulmonary dysplasia (BPD)
TP-114: A pulmonary sandstorm: a rare case of pulmonary alveolar microlithiasis
TP-115: Impact of pulmonary artery wedge pressure on clinical phenotype, treatment response and survival in idiopathic pulmonary arterial hypertension
TP-116: An unusual case of recurrent haemoptysis
TP-117: Pulmonary graft versus host disease – assessment of local screening and diagnostic practices
TPL-013: Understanding the patient's experience of care in idiopathic pulmonary fibrosis
TPL-014: The E3 ubiquitin ligase MID1 promotes idiopathic pulmonary fibrosis
Paediatric
TP-118: Transitioning young adults with Bronchiectasis – challenges and pitfalls
TP-119: What is the concordance of parent and doctor report of a child's cough?
TP-120: Are our children safe? Estimated CT radiation doses in the diagnosis of non-CF bronchiectasis
TP-121: Long-term morbidity of respiratory viral infections during chemotherapy in children with leukaemia - pilot study
TP-122: Vomiting associated with cough- not always post-tussive!
TP-123: Prospective study investigating the burden of empyema using the New Zealand Paediatric Surveillance Unit
TP-124: Acute respiratory illnesses and related respiratory morbidity in preterm infants during the first 6 months of life
TP-125: Description of an inpatient overnight ward sleep oximetry service
TP-126: The relationship between forced oscillation and the COPD Assessment Test in stable COPD
TP-127: Outcomes of the multiple sleep latency test (mslt) for narcolepsy (N) and idiopathic hypersomnolence (IH) using different diagnostic criteria
TP-128: Changes in Peripheral airway function at 12 months post allogeneic haematopoietic stem cell transplantation (allo-HSCT)
TP-129: Audit of adaptive servoventilation at the prince charles hospital in the post serve–hf trial era
TP-130: Hypercapnia is not associated with increased complication rates in Motor Neuron Disease (MND) patients undergoing Percutaneous Endoscopic Gastrostomy (PEG) insertion
TP-131: The effect of spectral leakage on the forced oscillation technique
TP-133: Firefighting self-contained breathing apparatus is not an independent risk factor for airway hyperresponsiveness
TP-134: Nocturnal angina in severe REM obstructive sleep apnoea
TP-135: Partial anomalous pulmonary venous connection presenting as eisenmenger's syndrome
TP-136: Clinical outcomes in patients with REM-related obstructive sleep apnoea treated with continuous positive airway pressure (CPAP) therapy
TP-137: Negative predictive value of pulse oxygen saturation cut-offs in excluding resting hypercapnia and overnight hypoventilation in stable patients undergoing sleep studies
TP-138: Blood neutrophils relate to lung volume and DLCO in older asthmatics with fixed airflow obstruction
TP-139: How often do continuous positive airway pressure (CPAP) users clean their equipment?
TP-140: Efficiency of Oxygen Concentrators in a Simulated Aircraft Cabin Environment
TPL-015: Two year outcomes of a Non-Invasive Ventilation (NIV) program in a tertiary hospital demonstrate lower mortality
TPL-016: The effect of early age at menarche on adult lung function
Primary Care, Lung Cancer and Beyond
TP-141: respManagement of non-cystic fibrosis bronchiectasis in the Kimberley region of Western Australia
TP-142: Drawing asthma: An exploration of patients’ perceptions and experiences
TP-143: Tumour pseudoprogression following stereotactic ablative body radiotherapy for early stage NSCLC
TP-145: Delivering advance care planning to patients with chronic lung disease in a respiratory outreach program
TP-146: Prevalence of illegal inhalant use among patients undergoing respiratory function tests at western health
TP-147: Palliative care nurses’ attitudes and perceived barriers to COPD-related advance care planning: preliminary findings from a cross-sectional survey study
TP-148: Respiratory patient experiences in self-managing Emergency Department ‘near-miss’ for breathlessness: a strengths-based qualitative study
TP-149: A non-invasive ventilation and airway management evidenced-based eLearning resource can be used to transfer knowledge to health care professionals
TP-150: Case report: Isolated pauci-immune pulmonary capillaritis (IPIPC)
TP-151: Case series report: Primary amyloid lung disease
TP-152: A case of platypnoea orthodeoxia following abdominal surgery
TP-153: Impact of streamlined lung cancer triaging on timeliness of care in a quaternary centre
TP-154: EGFR Exon 19 Deletion Related Non-Small-Cell Lung Cancer Manifesting as Diffuse Pulmonary Miliary Infiltrates
TP-155: Is avoidable really avoidable? A review of Thoracic Medicine admissions classified as avoidable in a NSW Teaching Hospital
TP-156: Primary Pulmonary Leiomyosarcoma presenting as Unrelenting Cough
TP-157: Integrated care for COPD: Protocol for a physiotherapist and general practitioner partnership model of care
Respiratory Infectious Diseases
TP-158: Community acquired pneumonia audit tool identifies unwarranted variation in indicators of clinical care to target service improvements
TP-159: Improving length of stay in community acquired pneumonia
TP-160: Pneumonia with brachial plexopathy
TP-161: The limited role of Mycoplasma pneumoniae serology and PCR in the diagnosis of mycoplasma infection at the Gold Coast University Hospital
TP-163: Assessment of pneumonia severity score documentation, admission criteria and initial treatment plan of patients with pneumonia in Hornsby hospital in September and October 2015
TP-164: Diabetes screening among active TB patients in WA TB control program using HbA1c. A pilot study
TPL-017: Multi-drug resistant tuberculosis in Queensland, Australia 2000–2014
TPL-018: Mycobacterium shimoidei – a rare but increasingly recognised pulmonary pathogen